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ABSTRACT
Ionizing radiation has been associated with various cardiovascular
complications; however, the associated molecular changes from radiation
exposure still remain largely uncharacterized. Alterations to the cardiovascular
tissue microenvironment, i.e. the extracellular matrix (ECM), directly affect the
function of integrated vascular cells, including cell adhesion, potential to form
vessels, and endothelial permeability, which can promote cardiovascular
pathologies. The ECM is constantly remodeled in response to stimuli, such as
TGF-β1, which leads to excessive ECM accumulation. We hypothesize that
radiation exposure will alter the cardiovascular ECM. Human Cardiac Fibroblasts
(HCFs) were utilized to produce ECM as an in vitro model to study changes in
cardiovascular ECM from exposure to 0 and 1 Gy of γ-radiation. We verified that
the ECM produced by these cells over 7 days of culture contained collagen and
fibronectin. HCFs were radiosensitive to 1 Gy of radiation, as the irradiated cells
exhibited γ-H2AX foci.

Intracellular reactive oxygen species (ROS), a known

activator of latent TGF-β1, was increased in HCF immediately after radiation. In
addition, irradiated HCF contained SMAD 2/3 in their nuclei and expressed αsmooth muscle actin, which are indicative of TGF-β1 activation. Measurement of
total ECM protein and morphology demonstrated an increase in ECM protein
production and an altered ECM structure from HCF exposed to 1 Gy radiation
compared to sham control. In conclusion, we demonstrate that ionizing radiation
induces structural and molecular changes in cardiovascular ECM.
v

Our data

further indicates that γ-irradiation activates TGF-β1 downstream signaling
cascades, which may be a primary contributor of ECM remodeling in vascular
tissue. Future studies relating ECM remodeling and cardiovascular cell function
may help improve our understanding of cardiovascular risks from radiation
exposure.
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NOMENCLATURE
β-radiation

Beta radiation

γ-radiation

Gamma radiation

ROS:

Reactive Oxygen Species

AOX:

Antioxidant

ECM:

Extracellular Matrix

FN:

Fibronectin

3D:

Three Dimensional

GAGs:

Glycosaminoglycans

Col I:

Collagen I

Col III:

Collagen III

TGF-β:

Transforming Growth Factor Beta

α-SMA:

Alpha Smooth Muscle Actin

HCF

Human Cardiac Fibroblasts

FBS

Fetal Bovine Serum

PS:

Penicillin/Streptomyosin

(v/v)

Volume per volume

(w/v)

Weight per volume

µg

Microgram

mg

Milligram

µL

Microliter

mL

Milliliter

µM

Micromolar

mM

Miliimolar

DIH2O:

Deionized Water

Gy:

Grey

PEG Catalyse:

Polyethylene Glycol Catalyse

MnTBAP:

Manganese (III) Tetrakis (4-Benzoic Acid) Porphyrin Chloride
viii

°C

Degrees Celsius

1X – PBS

1X – Phosphate Buffer Saline

+Ca/Mg:

Plus Calcium and Magnesium

NR

Not Radiated (0 Gy)

R

Radiated (1 Gy)

NR-AOX

Not Radiated with Antioxidant

R-AOX

Radiated with Antioxidant

DCFH-DA

2’, 7’-di-chloro-di-hydro-fluorescein diacetate

DMSO:

Dimethyl Sulfoxide

H2O2

Hydrogen Peroxide

DNA:

Deoxyribonucleic Acid

γ-H2AX:

Gamma H2A Histone Family, member X

FA

Formaldehyde

DAPI

4',6-Diamidino-2-Phenylindole, Dihydrochloride

NIH

National Institute of Health

AF

Alexa Flour

RT

Room Temperature

DNAse

Deoxyribonucleic Acid-ase

dECM:

Decellularized Extracellular Matrix

BCA

Bicinchoninic Acid

RIPA

Radioimmunoprecipitation

WR

Working Reagent

Cu+2

Copper (II)
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I.

INTRODUCTION
Radiation
Exposure to ionizing radiation is an important concern in medical

radiotherapy

[1]

, occupational exposure

[2-4]

, and manned space flight

[5]

.

Different types of ionizing radiation can include Beta radiation (β-radiation),
gamma radiation (γ-radiation), and high energy cosmic (HEC) radiation.
γ-radiation can penetrate several centimeters into the skin, whereas gamma
radiation (γ-radiation) can penetrate through the skin and into the human body.
Exposure to γ-radiation injury can induce morphological and functional changes
in noncancerous or normal tissue.

Associated hazards of ionizing radiation

exposure can include the development of cardiovascular diseases, carcinogenic
events

[6]

, and congenital abnormalities

[7]

. Many studies have indicated a strong

connection between ionizing radiation exposure and diseases; however, little is
known about the pathophysiology of these phenomena. Although, it is a widely
accepted fact that ionizing radiation induces an excess in exogenous reactive
oxygen species (ROS). [8] These ROS species may prove to shed insight into the
mechanism(s) linking ionizing radiation to a variety of diseases.
ROS refers to chemically reactive molecules (free radicals) with oxygen,
such as peroxides, hydroxyl radicals, and singlet oxygens. ROS are important
homeostatic molecules in non-diseased states. However, shifts in the equilibrium
of ROS and ROS scavengers, known as antioxidants (AOXs), can induce oxidative
stresses in cells and tissues.

This oxidative stress contributes to non1

homeostatic conditions in the cell’s microenvironment as well as induces DNA
damage

[9]

. One possible way to cause this shift in equilibrium is via ionizing

radiation exposure. In order to combat this equilibrium shift, cells utilize intrinsic
(superoxide dismutase, catalase, glutathione, proteins, etc) and extrinsic (vitamin
C and E, polyphenols, carotenoids, etc.)
produced ROS.

[10, 11]

AOX that scavenge excessively

The basic mechanism behind AOX requires that they

donate electrons to ROS molecules in order to “deactivate” the free radical from
causing oxidative stress. The balance of ROS and AOX activity is an ongoing
process throughout the cell’s entire life.
The

continually

changing

proportions

of

ROS

and

AOXs,

both

intracellularly and extracellularly, create a diverse environment that makes
modeling in-vivo conditions challenging for the accurate predictions of the risks
of radiation.

Previous methods of modeling human radio-sensitivities include

coupling empirical evidence with radiative transfer models
models

[13]

[12]

, biophysical

or normal tissue complication probabilities. [14] However, these models

only utilize uniform irradiation of populations at high doses whereas Ward et. al
[15]

has proven even significant effects can occur at low doses.

Moreover,

these models do not propose any new advances in understanding the
mechanisms underlying irradiation exposure and its effects on cells
and tissues.

Advances in cell culture methods, multidisciplinary

research, and an increased clinical need for treatment of radiation
induced injuries has led to a paradigm shift utilizing in-vitro models to
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elucidate the biological mechanisms involved in pathophysiological
conditions resulting from radiation exposure.

Radiation Effects on the Cardiovascular Environment
It is now recognized that the heart is susceptible to radiation exposure. [16]
Many negative effects have been associated with mediastinal irradiation. Effects
can include coronary artery disease, pericarditis, cardiomyopathy, valvular
disease, and conduction abnormalities.

Some of these effects have been

observed in populations of cancer patients receiving radiation treatment
nuclear industry workers,

[2, 4]

, and atomic bomb survivors

[5, 17, 19]

.

[5, 17]

,

These

observations have also suggested radiation-associated cardiovascular toxicity
may be progressive.

[18]

Atomic-bomb survivors presented premature aortic arch

calcification, isolated systolic hypertension, and myocardial infarction

[16, 19]

.

Moreover, patients receiving radiation therapy for Hodgkin’s disease or left-sided
breast cancer demonstrate an elevated risk of coronary heart disease,
arteriosclerosis, atherosclerosis, and late-pulmonary fibrosis

[20,22-26,34,35]

.

Many of the aforementioned cardiovascular diseases are linked in that
their pathologies show an increase in vascular stiffness.[27-29] Arterial stiffness
develops from complex interactions between stable and dynamic changes
involving structural and cellular components.

[30-32]

The main structural

components of the arterial wall are two extracellular matrix (ECM) proteins:
collagen and elastin.

Collectively these proteins determine resilience,
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compliance, and stability of the vessel wall.

In diseased states, there is a

dysregulation in the balance of these proteins as well as chondroitin sulfate,
heparin sulfate, proteoglycans, and fibronectin (FN)

[31]

.

Some ECM matrix

proteins contain cryptic sites which are active fragments that are not normally
exposed in the protein. These sites are exposed by structural or conformational
changes in the ECM protein and lead to altering the structural (matrix assembly,
fiber alignment, composition) & mechanical (elastic moduli, stiffness, and
porosity)

[33]

properties of the ECM directly. These local changes can in turn

cause global affects through signal transduction cascades in the function of
integrated vascular cells such as endothelial cells, fibroblasts, and vascular
smooth muscle cells.

ECM and Cell Signaling
The ECM has long considered to be an inert, purely supportive, 3D network
of proteins (collagenous and non-collagenous) and glycosaminoglycans (GAGs)
for the cellular microenvironment. Additionally, the matrix provides a medium
for cellular migration and interaction during their development, homeostasis, &
regeneration. Moreover, it can provide an adhesive substrate for cells, transduce
mechanical

signals,

regulate

cell

morphology

and

functions,

such

as

differentiation, proliferation, and migration, and sequester and store cytokines,
such as growth factors

[8,10,36]

. Cellular responses are tissue dependent in terms

of both biochemical and biomechanical cues.
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Hence, understanding the

complexities surrounding ECM production, modification and remodeling, and
relating these processes to physiological changes in the biochemical and
biomechanical

properties

of

the

ECM,

are

key

to

determining

how

microenvironmental changes influence cellular responses.[37] Thus, the cell’s fate,
life and death, is ultimately related to and dependent on the interaction,
composition, and organization of the matrix.
Each component of the ECM is unique and together the ECM components
dictate the mechanical, structural, and biochemical microenvironment. For
example, collagen I (Col I) fibrils provide tensile strength, collagen III (Col III)
fibrils colocalize with collagen I fibrils and modulate its production, and
proteoglycans, such as FN, act as adhesive substrates for cells and other matrix
proteins

[8,38-39]

.

Due to the negative charge of GAGs, they’re able to alter

activities of other molecules such as fibroblast growth factor, chemokines,
cytokines, and those of the transforming growth factor family.

[38,40]

. In most

connective tissue, ECM is primarily produced and organized by fibroblasts, which
are constantly remodeling the ECM through the peptide growth factor regulated
matrix metalloproteinases and their inhibitors.
Peptide growth factors are small proteins that regulate cell differentiation,
proliferation, and apoptosis.

Those of the transforming growth factor family

(TGF-β) are molecules that are also highly involved in regulating the ECM and
have been noted to play a significant role in the regulation and growth of
normal, hyperplastic, and malignant prostatic epithelium. TGF-β is a broad term
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encompassing five different conformations of the protein (TGF-β1-5) with only
TGF-β1-3 expressed in mammals.

Specifically, TGF-β1 upregulates several

fibrotic genes encoding fibronectin, collagens, and can activate other proteins
through its type I receptor.

[41]

Fibroblasts secrete TGF-β1 as an inactive

precursor as part of a protein complex where the ECM acts as a reservoir of this
quiescent TGF-β1

[42-44]

.

For TGF-β1 to bind to its cell receptor, it must be

activated by low pH, proteases, deglycosylation, plasmin, thrombospondin,
integrins, radiation exposure, and ROS as well as other mechanisms
cancer models, ROS are extremely efficient activators of TGF-β1

[45-47]

[42,46]

. In

. This

activated TGF-β1 is then free to interact with its associated receptor kinase on a
cell membrane. Upon binding to the receptor it induces fibroblast differentiation
into

myofibroblasts

which

express

α-smooth

muscle

actin

(α-SMA).

Myofibroblasts are associated with diseased states characterized by excessive
ECM secretion. Abnormal radiation induced production of TGF-β1 has already
been linked to cancer progression
gut and liver

[50]

[48,49]

and development of fibrosis in skin, lung,

. Limited studies have explored the effects of TGF-β1 on

cardiovascular ECM and its role in cardiovascular disease progression.

Fibroblast-derived ECM
Cell derived ECM scaffolds have been more recently explored as alternatives
to investigating cellular and protein level changes in tissues. These ECMs are
naturally produced by fibroblasts and have been shown to be similar in
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composition, microstructure, biochemical properties, and bioactivity to those of
the native tissues and organs.

[51, 52]

These ECMs are a multi-component 3D

scaffold containing proteins, GAGs, and growth factors

[44, 52]

. The mechanical

properties of cell derived ECM have been examined. Decellularized ECM (dECM)
has been additionally utilized in studies in order to show its effects on cell
adhesion, endothelial tubulogenesis, and other cell processes as they relate to
disease progression.

[53, 54]

Moreover, TGF-β1 activation has been investigated

using decellularized lung fibroblast-derived matrices

[44]

whereas few studies

have examined non-homeostatic conditions on cell derived cardiovascular
matrices and how they relate to cardiovascular disease progression.

7

OBJECTIVE
We hypothesize that a human cardiac fibroblast in vitro model can be
designed in order to investigate that γ-radiation exposure increases ROS, which
contributes to the increased production of ECM proteins thus altering their
structure and function. In order to achieve this goal, the process was threefold:
1. Develop a fibroblast cell culture model that allows for the production of a
cardiovascular specific decellularized ECM
2. Examine the radiosensitivity of the fibroblast model developed in aim 1
3. Investigate radiation-induced changes to the decellularized ECM produced
by cardiac fibroblast
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II.

PROCEDURE
Culturing of Fibroblasts
HCFs were obtained from Promocell and cells were cultured in Fibroblast

Growth Medium 3 (Promocell) supplemented with 10% fetal bovine serum (FBS;
Atlanta Biochemical) and 1% penicillin/streptomyosin (PS; HyClone).
subcultures

were

seeded

at

a

minimum

density

of

4000

All

cells/cm2.

All experiments were conducted with HCFs less than or equal to passage 6.

Seeding Cell Culture Plates to Produce ECM
ECM was produced on either 12 mm fibronectin coated glass coverslips
(Fisherbrand) or 30 mm fibronectin coated sterile 6 well culture plates (Costar).
Coverslips were sterilized by submerging each coverslip in 70% (v/v) ethanol
(Decon Labs) for 30 seconds and allowed to air-dry and placed into wells of a 12
well plate. Plate wells were then treated with either 1 or 2 mL (6 or 12 well
plate, respectively) of a 50 μg/μL (w/v) fibronectin (Corning) solution in
deionized water (DI H2O). Once the fibronectin solution was added, the plates
were then incubated for 1 hour at 37°C to allow the fibronectin solution to coat
the coverslips or wells. Coating with fibronectin allowed the ECM produced by
the HCFs to stay attached to the cell culture plates and coverslips post
decellularization.

Cells were then added to all necessary wells at 100%

confluence to 6 or 12 well plates (40,000 or 200,000 cells/well, respectively) post
incubation. Upon addition to cell culture plates, HCFs were cultured for 14 days
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with media changes every 2 to 3 days. For ECM requiring experiments, cells
were radiated with 0 or 1 Gy of γ-radiation and/or treated with an AOX
(immediately before radiation) on day 7 using a Gammacell 40 Extractor (MDS
Nordion) irradiator. For cell only requiring experiments, cells were cultured for
only 3 days with radiation exposure and/or AOX treatment on day 3. 1 Gy of γradiation was used due to mandates set by the funding institution.

Preparation of Antioxidant Cocktail
An AOX cocktail was utilized in order to reduce any ROS generated from
γ-radiation exposure. The reduction in ROS is used to compare the effects of
diminished ROS on the cells and their microenvironment (ECM) to that of the
base conditions, 0 or 1 Gy of γ radiation. The specific concentration of the AOX
cocktail used across all experiments was a mixture of a 103 Units/mL of
polyethylene catalase (PEG catalase; Sigma) and a 10 μM solution of Manganese
(III) tetrakis (4-benzoic acid) porphyrin chloride (MnTBAP; Calbiochem). This
AOX cocktail was used due to its structure and mechanisms. Structurally, these
AOXs are able to have successful cellular uptake upon exogenous treatment.
Mechanistically, the treatment of these two allow for an effective two step
procedure for reduction ROS (MnTBAP reduction of ROS to H2O2 followed by
catalase reduction of H202 to water).

[55]

PEG catalase was initially a 1 mg

lyophilized powder and was reconstituted based on manufacturer specifications
in a 1:1 solution of DI H20 and Glycerol (Sigma) for a total of 2 mL.
10

This

resulting 0.5 mg/mL solution was placed into 50 μL aliquots and frozen at -20°C
until further use. The MnTBAP was freshly prepared before each experiment
with 1 mg of MnTBAP reconstituted in 2 mL of a

.01 M Tris base solution

(Sigma; pH ~ 7.0 -7.4; 36.3 mg Tris base dissolved in 3 mL of DI H2O). This
resulting concentration of 0.5 mg/mL MnTBAP was used in obtaining the desired
concentrations of the AOX cocktail needed for each experiment. To obtain the
desired concentration, the AOX is mixed in the ratio of 51.3 μL of PEG catalyse to
17.5 μL of MnTBAP to 931.2 μL of 1X-phosphate buffered saline (v/v)
supplemented with 0.9 mM Ca+2 + 0.5 mM Mg+2 (1X-PBS (+Ca/Mg)) for a total
of 1 mL AOX created. These ratios were adjusted throughout all experiments to
obtain the necessary volume of the AOX cocktail needed.

All solutions and

powders were kept on ice and handled in low light due to the stability of the
AOX.
The AOX cocktail is utilized in creating the 4 experimental conditions in
Table 1 for all further experiments.

In order to compare the effects of AOX

treatment on cells and ECM production, all appropriate HCFs were introduced
with the AOX cocktail immediately before irradiation.
TABLE 1: Experimental Conditions
RADIATION (0 or 1 Gy)
ANTIOXIDANT

0 Gy/No Antioxidant (NR)

1 Gy/No Antioxidant (R)

(+ or -)

0 Gy/Antioxidant (NR-AOX)

1 Gy/Antioxidant (R-AOX)
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Detection of ROS in HCFs
HCFs were seeded at 10,000 cells/well in 15 wells across 2 flat black 96
well plates (Costar) for a total of 30 wells seeded (3 conditions per plate, 5
replicates per condition, 2 plates designated NR and R). Based on previous work
in the lab, cells were not seeded along the outer wells of each plate in order to
avoid plate reader induced errors of measurements.

All further work was

completed in low light conditions due to the photo stability of the AOX and dyes
used in the procedure.
Following one night of incubation, cell media was vacuumed up from each
well and cells were washed for 5 minutes with 100 μL of a sterile 1X-PBS
+Ca/Mg solution. This mixture of PBS was used in order to avoid cell lysis or
shrinkage.

After 5 minutes, the PBS solution was vacuumed off and all cells

were treated with 100 μL of a 10 μM 2’, 7’-di-chloro-di-hydro-fluorescein
diacetate dye (DCFH-DA; Life Technologies) in 1X-PBS +Ca/Mg and incubated at
37°C for 30 minutes.

DCFH-DA is normally a lyophilized powder that was

reconstituted in 8.16 μL of DMSO to create a stock 10 mM solution.

Post

incubation, all wells were washed with 1X-PBS +Ca/Mg and then treated again
with 100 μL of the 1X-PBS +Ca/Mg solution.

1 mL of the AOX cocktail was

created prior to use, using the methods described in the preparation of AOX
section.

Both plates were then taken to the irradiator and prior to radiation

exposure AOX wells were aspirated of the PBS solution and treated with 100 µL
of the AOX solution. The plates were then exposed to 0 or 1 Gy of γ radiation.
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During incubation with DCFH-DA, intracellular esterases will cleave acetate
groups in the dye allowing it to “tag” oxygen species. Further esterase cleavage
of lipophilic blocking groups creates a charged form of the dye allowing the dye
to be retained by the cell. Upon oxidation of the cell through the generation of
ROS, the dye becomes fluorescent (excitation: 492-495 nm; emission: 517-527).
This fluorescence can then be measured and directly correlated to levels of ROS
within the cells.
Immediately following radiation, the plates were then taken to a
microplate reader and measured for fluorescent intensity using the conditions in
TABLE 2.
TABLE 2: Microplate Reader Settings
SHAKING
Duration:
30 sec.
Amp. :
3 mm.
Type:
Orbital

FLUORESCENCE INTENSITY
Excitation:
Lag Time:
Settle Time:
485 ± 20 nm
0 sec
0 sec.
Emission:
Integration Time:
Manual Gain
535 ± 25 nm
20 sec
Multiple Reads Per Well:
Mode: Top
# of flashes: 25
Circular

As a positive control, freshly prepared 100 μM hydrogen peroxide (H2O2;
Fisher Scientific) was added to all wells of the NR plate upon completion of its
read as well as after the R plate’s reading. The NR plate was replaced and read
again with the addition of H2O2. Similar methods applied to the R plate. H2O2 is
a form ROS and was used to validate the activity of the DCFH-DA. Negative
control conditions included samples with no cells with only DCFH-DA and cells
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with no DCFH-DA to establish any auto-fluorescent levels. Average fluorescent
values in each well were reported from the plate reader and these values were
then averaged in Microsoft Excel across all conditions (n=5) to find average
DCFH-DA fluorescence per condition.

This level of DCFH-DA fluorescence

directly relates to levels of active ROS present in HCFs.

The average

fluorescence for each condition was then normalized to the NR no treatment
condition.

The results were analyzed for equal standard deviations using

statistical software (Minitab).

Significance is reported by using a one-way

ANOVA coupled with a Tukey post-test (α=.05).

ANOVA residuals were

examined to validate normal distribution.

Determining ROS Damage to HCFs
An excessive production of γ-radiation induced ROS can lead to DNA
damage.

[56]

Cells use the phosphorylated H2AX protein (γ-H2AX) as an indicator

for DNA damage (double strand breaks). Thus, this protein is used as a widely
accepted immunofluorescent marker for DNA damage. It was used here as a
marker for any damage created by an excess in ROS production by ionizing
radiation.
Cells were seeded on fibronectin coated coverslips at 100% confluence.
The discussed staining protocol was adapted from Wilson et. al

[57]

.

After

attachment the cells were treated with media containing 0.2% FBS for 2 days,
halting proliferation of HCFs. All samples were then subjected to either 0 or 1 Gy
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of γ-radiation and treated with AOX appropriately.

Immediately following

radiation, samples were fixed with a 4% formaldehyde (FA) solution (v/v)
(Sigma) in DI H2O for 20 minutes. Cells were then permeablized with a 0.1%
triton solution (v/v) (Sigma) in 4% FA for 5 minutes. This permeabilization step
punctures micro-holes within the cellular and nuclear membranes in order for
antibodies to enter the cell and to accurately find their targeted biomolecule. All
samples were then washed twice with 1X-PBS for 5 minutes each (this procedure
here on out refers to “cells were washed”). After permeabilization, the cells were
then treated 30 minutes with an image ITFX signal enhancer (Thermo Fisher)
which allows for the mitigation of any nonspecific binding.

Cells were then

washed and treated with a 1:250 dilution of a primary antibody (anti-γ-H2AX;
Millipore) for 1 hour at 37°C.

Once the cells were tagged with the primary

antibody, samples were washed and treated with a 1:50 dilution of a secondary
antibody (goat-anti mouse IgG CY3 conjugate; Millipore) for 1 hour at 37°C.
Secondary antibodies are naturally fluorescent and are designed in order to tag
the conjugated primary antibody, allowing for the target molecule, γ-H2AX in this
case, to be visualized through fluorescent imaging.
Post antibody treatments, cells were then washed and treated with a 4%
FA solution for 20 minutes in order to crosslink the antibodies together to allow
for optimal stability of the fluorescence in the secondary antibody. Once the
crosslinking step was completed, the cells were counterstained with a 1000 µM
4', 6-diamidino-2-phenylindole-dihydrochloride (DAPI; Life Technologies)
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solution for 5 minutes at room temperature (RT) in order to stain all nuclei. Cells
were then washed 3 times with 1X-PBS for 5 minutes each and then washed
twice with DI H2O for 10 minutes each and then mounted on 3 inch microslides
(VWR) with 15 µL of a fluorsave reagent (Millipore). Slides were imaged using a
Nikon Confocal microscope at 40X magnification. Two images were taken for
each coverslip.
regions of cells.

Stains for γ-H2AX are concentrated foci within the nuclear
The numbers of foci per nuclei across all images was

determined using Image J software and a Focinator macro created by NIH.
Settings for this macro are listed in table 3. Background and front channels were
selected based on the arrangement of composite images within the software. An
automatic thresholding technique was used in order to mitigate subjective error.
Through testing multiple thresholding processes, a Monuments design was
decided upon due to its effectiveness in isolating the γ-H2AX foci. In order to
optimally select foci and to only have complete nuclei considered, the fill holes
option was selected as well as all cells on the outer edges were discarded from
the analysis.
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Table 3: NIH Focinator Software Settings
Focinator Settings
Background Channel

Blue

Front Channel

Red

Manual Threshold

No

Mode of Threshold

Monuments

Fill Holes

Yes

Exclude Cells on Outer Edges

Yes

Nuclei were counted for each image and number of foci were counted
using the find maxima setting within ImageJ. Noise levels for foci counting were
set based on NR conditions and preserved through all measurements. Number
of foci per nuclei were then calculated and averaged across coverslips and then
averaged across all conditions (n=6, n=3 for NR-AOX) and normalized to the NR
no treatment condition.

The n value of 3 for NR-AOX treatment was due to

limited AOX resources and is preserved through all experiments for here on out.
Results were analyzed for equal standard deviations by using software (Minitab).
Significance was determined by completing a one-way ANOVA coupled with a
Tukey post-test (α=.05).

ANOVA residuals were examined in order to verify

normal distribution.
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Confirming TGF-β1 and SMAD 2/3 Activation in HCFs
ROS is a known activator of TGF-β1 and the relative amount of it was
verified by staining HCFs for TGF-β1. Downstream signaling in response to TGFβ1 binding to its cell receptor can lead to translocation of SMAD 2/3 to the
nucleus. SMAD 2/3 localization in the nucleus was also verified by staining HCFs
for this protein in order to confirm activation of this pathway.

Cells were

collected in a similar fashion as in the γ-H2AX protocol, minus the treatment with
low serum media. After 3 days of culture with media, all samples were taken to
the irradiator and exposed to either 0 or 1 Gy of γ radiation and appropriate
wells treated with AOX.

Cells to be analyzed for TGF-β1 were then fixed

immediately [58], while SMAD 2/3 samples were fixed 6 hours post radiation. [59] A
4% FA solution in 1X-PBS was given to the cells for 20 minutes for fixation. Cells
were then permeablized with a 0.1% triton solution in 4% FA for 5 minutes. All
sets of coverslips were then washed twice with 1X-PBS for 5 minutes for each
wash. This washing procedure will thus be referred to as “cells were washed.”
After the initial washings, the cells were then treated with a 1:50 dilution (antiTGF-β1; Santa Cruz) or a 1:30 dilution (anti-SMAD 2/3; Santa Cruz) of a primary
antibody and incubated for 1 hour at 37°C. Once the cells were tagged with the
primary antibody, they were then washed and treated with a 1:30 dilution of a
secondary antibody (goat anti-rabbit IgG Alexa Flour 555 conjugate (AF 555);
Life Technologies) for 1 hour at 37°C. Once the secondary antibody was applied,
the cells were washed and counterstained with a 1000 µM DAPI solution for 5
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minutes RT in order to stain all nuclei. Cells were then washed 3 times with 1XPBS and then washed once with DI H2O.

All coverslips were then mounted

similarly as in the determining ROS damage section.
Slides were imaged using a Nikon Confocal microscope at 40X
magnification. Two images for each coverslip was obtained. TGF-β1 slides were
analyzed using Nikon Elements Advanced Research Analysis software by
calculating the sum fluorescence intensity in each image. Nuclei were counted
for each image and the sum intensity for each image was normalized to the
number of nuclei within each image. These values were then averaged across
coverslips and then averaged across all conditions (n=6, n=3 for NR-AOX).
Average intensity per nuclei for all conditions were normalized to the NR no
treatment condition. An f test was completed in Minitab in order to confim equal
variances.

If failed, a Games-Howell post-test was used.

Significance was

determined by completing a one-way ANOVA coupled with a Games-Howell posttest (α=.05).

ANOVA residuals were examined in order to verify normal

distribution.
Analysis of SMAD 2/3 was conducted in a similar fashion with the sum
intensity only calculated within the nuclear regions of the images. Nuclei were
selected using the region of interest auto detect function within the software.
Nuclear regions were only considered to be positive staining due to the
localization of SMAD 2/3 within nuclei during times of its activation.

Sum

intensity per nuclei of each coverslip was then averaged across all coverslips and
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then averaged across all conditions (n=6, n=3 for NR-AOX). Results were
analyzed for equal standard deviations by using software (Minitab). Significance
was determined by completing a one-way ANOVA coupled with a Tukey post-test
(α=.05). ANOVA residuals examined confirmed normal distribution.

Determining Induction to Myofibroblasts
The induction of HCFs to myofibroblasts was determined by staining HCFs
for the myofibroblast indicator α-SMA. Cells were prepared in a similar fashion
as the γ-H2AX protocol, minus the treatment with low serum media. Appropriate
samples were treated with AOX and irradiated on day 3 of culture and all sets
were then fixed 24-36 hours post radiation.[60]

All fixation and staining

procedures were the same as in the TGF-β1 and SMAD 2/3 section. Cells were
stained with a 1:100 dilution of a primary antibody (anti-α-SMA; Santa Cruz) and
a 1:30 dilution of AF-555. Coverslips were mounted using the same procedure in
the determining ROS damage section.

Slides were imaged using the same

procedure as in the TGFβ1 and SMAD 2/3 section.

Samples were analyzed

similarly to TGF-β1 conditions with fluorescent intensity representing positive αSMA staining (n=6, n=3 for NR-AOX). Results were analyzed for equal standard
deviations by using software (Minitab). An f-test was completed in Minitab in
order to test for equal variances. If this test failed, a Games-Howell post used
was used.

Significance was determined by completing a one-way ANOVA
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coupled with a Games-Howell post-test (α=.05).

ANOVA residuals examined

confirmed normal distribution.
Visualizing the HCF Microenvironment and Isolation of dECM
The total composition and structure of the cell-ECM environment was
visualized by staining HCFs with a 1:100 dilution of an AF 488 carboxylic acid,
succinimidyl ester amino probe (Life Technologies) in order to fluorescently tag
all proteins.

Cells required for this experiment were acquired on fibronectin

coated coverslips after 14 days of culture with radiation on day 7. All fixation,
staining, and mounting procedures are similar to the confirming TGF-β1 and
SMAD 2/3 activation in HCFs. Images taken were used as a qualitative analysis
for comparing protein structure and amount for each condition.
To examine the effects of radiation on ECM remodeling, the HCFs were
extracted leaving an intact ECM to examine. Appropriate cells were treated with
AOX and irradiated on day 7 of culture. On day 14 of cell culture, fibronectin
coated coverslips or cell culture plates for all conditions were removed of cell
culture media and rinsed with 1X-PBS. A 0.1% triton X-100 solution (v/v) was
then added to each well containing coated coverslips or wells.

Plates were

placed onto a rocking plate and left at RT for 5-7 minutes to allow dissolution of
cellular membranes. Once membranes were removed, 100 µL of a 0.1% solution
of DNAse I solution (Roche) was placed into the same wells and allowed to
incubate for 1 hour at 37°C, or until all nuclei were no longer present.
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Decellularized ECM (dECM) samples were then rinsed twice with 1X-PBS and
then used for the appropriate experiments described in upcoming sections.

Examining Composition Changes in dECM
The composition of dECM (FN, Col III and I, and elastin) was determined
by staining dECMs for the all of the antibodies specific for these proteins. All
fixation and staining procedures are described in all previous antibody staining
sections. FN, Col III and elastin were stained on the same coverslips with 1:200,
1:10, 1:100 (respectively) dilutions of their primary antibody (anti-FN; abCAM)
(anti-col III; SouthernBiotech) (anti-elastin; Santa Cruz).

Samples were then

treated with 1:30, 1:50, and 1:100 dilutions of AF 555, AF 488, and AF 350,
respectively. (Life Technologies) Col. I was stained solely using a 1:200 dilution
of its primary antibody (ant-col I; abCAM) and a 1:50 dilution of AF 488.
1 z-stack was taken for each coverslip on a Nikon confocal microscope at 40X
magnification. Z-stacks allow for a 3D view of the dECM environment. These
stacks were then analyzed using the Nikon analysis software in order to
determine the volume of each protein present and the dECM’s anisotropy.
Volume is determined by thresholding each image within the z-stack and
applying this threshold to all images within the stack. This threshold selects all
positive stainings of the individual proteins.

Thresholds were determined by

selecting the values between 0 and 4095 (representing a 12 bit color image) that
maximized protein selection while minimizing noise selection. Threshold values
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were preserved across all conditions. Once thresholds were applied, the volume
measurement tool in the software calculates a volume of protein selected based
on the threshold. A percent protein can be determined by computing the ratio of
volume of the thresholded protein to that of the total volume of the stack.
These values were then averaged across all coverslips and all conditions (n=6 for
NR and R conditions, n =3 for NR-AOX and R-AOX conditions). Volume results
were analyzed for equal standard deviations by using software (Minitab).
Significance was determined for volumes by completing a one-way ANOVA
coupled with a Tukey post-test. (α=.05) Residuals were analyzed in order to
confirm normal distribution.

Examining Structural Changes in dECM
Thickness and anisotropy measurements were taken in order to
investigate any structural changes in dECM post γ-radiation exposure. Thickness
measurements were reported from the collection of z stack measurements and
then averaged across all coverslips measured (n = 9 for NR and R conditions, n
=3 for NR-AOX and R-AOX conditions). Lower n values were again due to limited
AOX resources. Average thickness for all z-stacks were then normalized to the
NR no treatment condition. Thickness measurements were analyzed for equal
standard deviations by using software (Minitab).

Significance for thickness

measurements was determined by completing a one-way ANOVA coupled with a
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Games-Howell post-test (α=.05). ANOVA residuals were examined in order to
verify normal distribution.
Structural organization of the dECM produced was analyzed by examining
the anisotropy, or preferred direction, of the dECM fibers. Maximum intensity
projections (MIPs) were taken from each z-stack which allow to view the highest
level of fluorescence within all z-stack images in one composite image. Each MIP
was analyzed for anisotropy using the FibrilTool macro in ImageJ.

[61]

This macro

measures the fractional anisotropy ratio of fibers within any microscopy image
based on the concept of a second order nematic tensor

[62]

. An area drawn

around the entire image was measured for its respected anisotropic value
ranging between 0 (less ordered; less restriction) and 1 (more order; more
restriction). Anisotropy fractions were averaged across all conditions (n=6 for
NR and R, n = 3 for NR-AOX and R-AOX) in Microsoft Excel and normalized to
the NR no treatment condition.

Minitab was used in order to test for equal

variances. Significance is determined by using a one-way ANOVA along with a
Tukey post-test (α=.05).

ANOVA residuals were examined in order to verify

normal distribution.

Quantification of Proteins Produced in dECM
The relative amount of proteins produced in ECM was determined by
using a bicinchoninic acid (BCA) assay adapted from Sigma Aldrich.

ECM

required for this experiment for two (NR and R) conditions (5 per condition) was

24

obtained in 6 well plates using methods described in the production of ECM and
isolation of ECM sections. Once decellularized, all ECM samples were placed on
ice and solubilized in 125 μL of a radioimmunoprecipitation (RIPA) buffer
(constituents listed in table 4). Samples were rotated for 3 minutes to allow for
proper distribution of RIPA buffer and then each well was scraped with a sterile
cell scraper (Falcon). Samples were then allowed to sit on ice for 3 additional
minutes to allow for optimal solubilization of ECM proteins. This protein-RIPA
solution was collected and used in the BCA assay.

TABLE 4: RIPA Buffer Components
SOLUTION
50 mM Tris Base +
150 mM NaCl
100 mM Sodium
Orthovanadate
200 mM EDTA
10% (w/v) Sodium
Deoxycholate
10% (v/v) Triton X100
10 mM Leupeptin
20 mg/mL Aprotonin

VOLUME

COMPANY

9.5 mL

Sigma

200 µL

Sigma

100 µL

Amresco

100 µL

Sigma

100 µL

Sigma

42 µL
10 µL

Sigma
Sigma

Once the ECM was solubilized and collected, 10 μL of samples from each
condition was pipetted into a 96 well plate. 5 replicates of each sample were
used. Additionally, 10 μL of standards ranging from 0 to 10 μg of protein were
pipetted into the plate in 5 replicates. Standards were created by serial dilutions
of a 1 mg/mL bovine serum albumin solution in RIPA buffer. Once all samples
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were prepared in the plate a working reagent (WR) was created by mixing two
separate reagents (A and B; Thermo Scientific) in the ratio of 50:1 based on the
necessary amount needed for each plate. Samples and standards were mixed in
the plate with a 1:8 ratio of the WR. Once mixed, the plate was incubated for 30
minutes at 37°C to allow for the WR to react with any present proteins. All
plates were read for absorbance at 562 nm using a BioTek microplate reader
with the conditions in table 5.
TABLE 5: Microplate Reader Settings
PARAMETER

SETTING

Assay

Quick Read

Wavelength

Single

Measure

562 nm

Plate Type

96 well

This biochemical assay measures protein concentrations within a solution.
This is accomplished by using a known two-step reduction of Cu+2 to Cu+1 by
proteins in alkaline mediums (the WR) using highly sensitive colorimetric
detection of the Cu+1 cation by BCA.
Within the first step of the reaction, samples are introduced into an
alkaline environment to form light blue complexes. These complexes then react
with BCA to produce an intense purple-colored reaction, strongly influenced by
amino acid residues, that results from the chelation of two molecules of BCA with
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one Cu+1 ion. This purple complex is water-soluble and exhibits a strong linear
absorbance at 562 nm.
Absorbance measurements obtained from the microplate reader were then
averaged across each sample using Microsoft Excel.

Using the standards,

average absorbance was then translated into average protein amounts.

Only

assays resulting in less than 10% standard deviation among the standards were
considered.

These were then averaged across all conditions (n=5) and then

normalized to the NR no treatment condition. Data obtained was then tested in
Minitab for normal distribution and equal variances. Statistical significance was
determined by using a t-test (α=.05).

Normal distribution was verified by

examining probability plots of the data collected.

Confirming Functional Endothelial Cell Changes on dECM
To determine if the changes in dECM alter endothelial cell (EC) function,
an aorta outgrowth assay was adapted from K Soucy et. al.[63] C7BL6 control
mice from another study were injected with a 0.9% physiological saline buffer
and were sacrificed 10 days post injection. Aortas were surgically isolated and
cut into 1-2 mm sections. A section of each aorta was placed onto NR and R
dECM prepared in a 6 well plate using methods described in the isolation of
dECM section. Aortas were allowed to attach to the dECM for 1 hour at 37ºC.
Post incubation, 3 mL of media supplemented with 0.0% FBS + 1.0%
PS/Glutamine (Gibco Medium 200; Life Technologies) was added slowly to each
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well, allowing the media to cover the aorta. Aortas were allowed to culture in
this media for 5 days with no media change. On the fifth day, aortas were fixed
using a 4% FA solution for 1 hour at RT and then imaged.
Phase contrast images were taken using a Nikon epifluorescent
microscope at 10x magnification. Two images per aorta were taken (3 NR dECM,
2 R dECM). Images were thresholded using software (Nikon Elements) in order
to isolate the growth area within each image by setting a threshold on the image
limiting brightness (0 to 4095) and size (0 to 5 µm). A polygon representing the
growth area was drawn using the polygon feature in the software. Area of the
polygon and area of thresholded areas within the polygon were then measured
using the measure function in the software. A percentage of area covered by
ECs within the growth area was then calculated using Microsoft excel. Threshold
values were preserved across both conditions. An average EC outgrowth area
percentage was calculated using Microsoft Excel and normalized to the NR no
treatment condition.

Results were tested for equal variances and normal

distribution using Minitab. Significance was determined by using a paired t-test
(α=0.5).

III.

RESULTS AND DISCUSSION
Detection of ROS in HCFs
ROS levels were measured by analyzing average fluorescence of DCFH-DA

in cells for all conditions. Results shown in figure 1 show a significant increase in
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ROS levels by approximately 20% (p*=.020) between NR and R conditions as
well as a significant decrease in ROS in both conditions treated with AOX when
compared to their no treatment conditions (p** and p*** < 0.0001). In addition,
we observe an increase in ROS for NR-AOX and R-AOX conditions, suggesting
slightly more ROS produced in R-AOX conditions. This verifies that exposure to
γ-irradiation increases the levels of ROS within the fibroblastic model.

Relative Fluorescent Levels

Average ROS Production in HCFs
*

1.4

**

***

1.2
1
0.8

0.6
0.4
0.2
0
NR

R

NR-AOX

R-AOX

Fig. 1: Relative fluorescent units in HCFs subjected to 0 and 1 Gy of γ radiation with and
without AOX treatment.

Determining ROS Damage to HCFs
ROS induced DNA damage to HCFs was examined by staining cells for a
marker of DNA damage, γ-H2AX, and analyzed using computer software (Image
J; Focinator). Representative images of γ-H2AX staining for each condition are
shown in figure 2.

The same images are shown in figure 3 after being ran

through the focinator software.

This analysis (figure 4) shows a significant
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increase in γ-H2AX foci in radiated HCFs (p* = .0004).

Moreover, not radiated

samples treated with AOX expressed significantly decreased numbers of foci (p**
< .0001) when compared to NR samples. Additionally, radiated samples treated
with AOX had significantly less foci per nuclei when compared to the R condition
(p*** < .0001) indicating that γ-H2AX foci present are dependent on AOX
treatment in both NR and R conditions. Moreover, we observed a nearly 2 fold
increase of foci present in R-AOX conditions when compared to NR-AOX
conditions,

indicating

further

ROS

dependent

expression

of

γ-H2AX.

The increase of ROS in radiated HCFs and the presence of γ-H2AX foci in HCFs
following γ-radiation exposure indicates that HCF are radiosensitive and that both

γ- H2AX + DAPI

ROS and γ-H2AX can be minimized with AOX treatment.

A

B

C

D

Fig. 2: Immunofluorescent images of γ-H2AX foci within HCFs for all conditions: (A) No
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar
indicates 20 microns.
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γ- H2AX THRESHOLD

A

B

C

D

Fig. 3: Threshold results of running γ-H2AX images through the focinator software. (A) No
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.

γ-H2AX Production in HCFs
*

Fold Increase
(# Foci/ # Nuclei)

2.00

**

***

1.50
1.00
0.50
0.00
NR

R

NR-AOX

R-AOX

Fig. 4: Relative levels of γ-H2AX foci present in HCFs exposed to 0 or 1 Gy γ-radiation for all
experimental conditions.
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Confirming TGFB and SMAD 2/3 Activation in HCFs
Relative levels of activation of TGF-β1, a known pro-fibrotic growth factor,
was analyzed by staining for any TGF-β1 present in HCFs for all conditions.
Representative images of TGF-β1 staining for each condition are shown in figure
5. Sum intensity per nuclei was measured (figure 6) and shows a significant 10fold increase in TGF-β1 staining expression in radiated HCFs (p* < .0001). This
increase is significantly attenuated in radiated samples treated with AOX
(p** < .0001) while the no radiation samples treated with AOX are statistically
similar to the NR no treatment condition.

This trend of TGF-β1 production

suggests that this pro-fibrotic growth factor is also a consequence of γ-radiation

TGF-β1 + DAPI

exposure and is ROS sensitive.
A

B

C

D

Fig. 5: Immunofluorescent images of TGF-β1 activation within HCFs for all conditions: (A) No
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar
indicates 50 microns.
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Fold Increase
( Sum Intensity/# Nuclei)

TGF-β1 Activationin in HCFs
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14.00

**

12.00
10.00

8.00
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2.00
0.00
NR

R

NR-AOX

R-AOX

Fig. 6: Relative levels of TGF-β1 activation in HCFs exposed to 0 or 1 Gy γ-radiation for all
experimental conditions.

SMAD 2/3 is activated in the presence of TGF-β1 and is a key contributor
in the regulation of many pro-fibrotic proteins. Thus, SMAD 2/3 was stained for
in HCFs for all conditions with representative images of SMAD 2/3 staining for
each condition shown in figure 7.
analyzed are shown in figure 8.

Images showing the regions of interest

Sum intensity of SMAD 2/3 staining in the

nuclear regions was measured (figure 9) and shows a reluctant increase in SMAD
2/3 staining expression in radiated HCFs by 30% (p = .110). This increase is
significantly mitigated in radiated samples treated with AOX (p* = .003) while
the NR samples treated with AOX are similar to the NR no treatment condition.
Moreover, we observed a 30.8% increase of SMAD 2/3 present in R-AOX
conditions when compared to NR-AOX conditions, indicating further ROS
dependent expression of SMAD 2/3,

This activity, similar to that of TGF-β1,
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suggests that the SMAD 2/3 pro-fibrotic pathway is additionally triggered by γradiation exposure and is also ROS sensitive (most likely as a result of the

SMAD 2/3 + DAPI

altered TGF-β1 activity).

A

B

C

D

Fig. 7: Immunofluorescent images of SMAD 2/3 activation within HCFs for all conditions: (A)
No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar
indicates 20 microns.
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SMAD 2/3 + DAPI

A

B

C

D

Fig. 8: Images with nuclear regions of interest selected for SMAD 2/3 images for all conditions:
(A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.
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Fig. 9: Relative levels of SMAD2/3 activation in HCFs exposed to 0 or 1 Gy γ-radiation for all
experimental conditions.
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Determining Induction to Myofibroblasts
Myofibroblasts are widely associated with their involvement in the excess
production of proteins. α-SMA is a widely accepted marker for their expression
and was stained for in order to validate the presence of myofibroblasts.
Representative images of α-SMA staining for each condition are shown in figure
10. Sum intensity per nuclei of each image was measured and data shown in
figure 11 suggests a significant 2.5 fold increase in α-SMA staining expression in
radiated HCFs (p* = .0008). Moreover, this increase is significantly decreased in
radiated conditions treated with AOX (p** < .0001). This activity indicates a γradiation and ROS dependent expression of α-SMA thus further suggesting that
downstream effects γ-radiation exposure can include a fibroblasts induction to
myofibroblasts and promote pro-fibrotic events.
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α-SMA + DAPI

A

B

C

D

Fig. 10: Immunofluorescent images of α-SMA expression within HCFs for all conditions: (A) No
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar
indicates 50 microns.
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Fig. 11: Relative levels of α-SMA expression in HCFs exposed to 0 or 1 Gy γ-radiation for all
experimental conditions.
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Visualizing the HCF Microenvironment and Isolation of dECM
The HCF microenvironment is a multi-faceted combination of cells and
ECM.

This environment is visualized in figure 12 with MIP images for each

condition. These images show a distinct structural difference in radiated samples
as well as a brighter staining in radiated samples which could indicate an
increased presence of protein. The ECM was decellularized (figure 13) in order
to further investigate composition and structural changes to the ECM post γradiation exposure. The lack of cells in 13B indicates that the detergent based
decellularizatoin protocol is an effective tool for isolating the ECM produced by

All Protein

HCFs.

A

B

C

D

Fig. 12: Representative images of the amino probe all protein stain within ECM for all
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with
AOX. Scale bar indicates 50 microns.
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Decellularized ECM

Cellularized ECM

Cellularized
ECM

B

A

Fig. 13: Phase contrast images of (A) cellularized extracellular matrix (ECM) and decellularized
ECM (B). Scale bars indicate 100 µM.

Examining Composition Changes in dECM
Representative composite maximum intensity projection (MIP) images for
the 3 channel ECM stained coverslips are shown in figure 14 for each condition.
Individual MIP images for FN and Col III channels are shown in figures 15 and
17, respectively. MIP images for the 1 channel ECM stained coverslips are shown
in fig 19 for the NR and R conditions. Thresholded images of FN, Col III, and Col.
I are shown in figures 16, 18, and 20 respectively. Elastin stains and volumes
are not reported due to no positive staining being observed.

AOX treated

collagen I conditions are not shown due to no observable difference in NR and R
no treatment conditions. Relative fold increases of FN, Col III, and Col I volumes
are shown in figure 21. Volume measurements show a significant 2 fold increase
in FN volume in radiated HCFs (p* = .0105). Additionally, the same trend is
observed with a 50.7% increase in FN production in R-AOX conditions when
compared to NR-AOX.

Furthermore, radiative groups treated with AOX show a

40% significant decrease in volume when compared to their radiated groups
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(p*** = .0075).

Fibronectin is a main ECM protein and when produced in

excess, as seen in radiative environments, is indicative of fibrosis environments.
Production of collagen I is decreased significantly by almost 80% between NR
and R conditions (p**=.036). All other conditions for collagen I production were
statistically similar. This contradictory result shown here to decrease in dECM by
75% is most likely indicating that collagen production is mandated by cells other
than HCFs, most likely smooth muscle cells, and/or is modified by ECM
remodeling proteins (cathepsins) post radiation exposure. No statistical
difference was observed in collagen III production, although there was an

Fibronectin + Collagen III + Elastin

observable decrease in Col III in the R condition.

A

B

C

D

Fig. 14: Composite maximum intensity projection images of fibronectin, collagen III, and
elastin expression within dECM for all conditions: (A) No Radiation, (B) Radiation, (C) No
Radiation with AOX and (D) Radiation with AOX. Scale bar indicates 50 microns.
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Fibronectin

A
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D

Fibronectin Threshold

Fig. 15: MIPs of fibronectin expression within dECM for all conditions: (A) No Radiation, (B)
Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar indicates 50
microns.

A

B

C

D

Fig. 16: Representative thresholded images of fibronectin expression within dECM for all
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with
AOX. Scale bar indicates 50 microns.

41

Collagen III

A

B

C

D

Collagen III Threshold

Fig. 17: MIPs of collagen III expression within dECM for all conditions: (A) No Radiation, (B)
Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar indicates 50
microns.
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Fig. 18: Representative thresholded images of collagen III expression within dECM for all
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with
AOX. Scale bar indicates 50 microns.
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Fig. 19: Representative images for collagen I production in NR (A) and R (B) conditions within
dECM. Scale bar indicates 50 microns.
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Fig. 20: Thresholded images for collagen I production in NR (A) and R (B) conditions within
dECM. Scale bar indicates 50 microns.
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Fig. 21: Relative amounts of fibronectin (black), collagen III (gray), and collagen I (orange)
production within dECM for all conditions.
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Examining Structural Changes in dECM
Structural changes to the dECM measured post γ-radiation exposure
included the thickness and anisotropy of the dECM. Thickness measurements
are presented in figure 22 and show a significant 60% increase in ECM thickness
between NR and R conditions (p*=.0005).

In addition, this increased ECM

thickness is significantly decreased in R and RAOX conditions (p**=.0059).
Collectively, this relationship implies protein production, and thus the thickness
of ECM, is increased in response to γ-radiation and is dependent on the presence
of ROS. Isotropic measurements are shown in figure 23 and report a significant
decrease in anisotropy (1 versus .23) between NR and R conditions (p*=.0004)
thus significantly altering the fibril structure and alignment of dECM. Moreover,
in AOX treated conditions, we observe a 23% decrease in anisotropy in R-AOX
conditions when compared to NR-AOX conditions. Interestingly enough though,
not only is radiation a contributor to anisotropy, but data shows here that
exogenous AOX treatment has a significant toll on dECM order.

NR and R

conditions treated with AOX are statistically less anisotropic (.4 and .3,
respectively) when compared to the NR no treatment condition (p**N-NA =.0122
and P***N-RA=.0044, respectively). This affect will have to be studied more in
order to obtain a clearer understanding of the chemistry involved in the
treatment of the AOX cocktail as well as the effect of AOX on the dECM.
Nonetheless, the more significant alteration in structure observed in radiated
dECM ultimately has the capacity to affect a slew of cellular and molecular
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characteristics possibly leading to the phenotypical conditions observed in
diseased cardiovascular states.

Thickness of dECM
Fold Increase (µm)

3.00

**

*

2.50
2.00
1.50
1.00
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R

NR-AOX

R-AOX

Fig. 22: Relative thickness of dECM for all conditions.
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Fig. 23: Relative anisotropic values for dECM treated with 0 or 1 Gy for all experimental
conditions. Values closer to 0 indicate higher levels of anisotropy.
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Quantification of Proteins Produced in dECM
Concentration of proteins produced in the dECM were quantified by using
the BCA assay.

Data (figure 24) expresses a significant increase of protein

concentration in R samples when compared to NR samples (p* = .0047). This
increase thus insinuates that radiation exposure contributes to an increased
protein production, most likely through the action of the TGF-1 and SMAD 2/3
pro-fibrotic pathways.

Moreover, this increased production of proteins is

primarily done through the action of HCFs induced to myofibroblasts.

Protein Concentration in R v NR HCFs
*

Fold Increase of
Protein (ug/uL)

1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
NR

R

Figure 24. Protein Production in R and NR HCF derived dECM.

Confirming Functional Endothelial Cell Changes on dECM
Representative images for EC outgrowth are shown in figure 25. These
same images are shown thresholded in figure 26. The analysis of EC outgrowth
(figure 27) reports an almost 100% observable decrease in outgrowth on R46

dECM. However, no significant changes (p =.499) are reported notably due to
variability of growth areas and low n-values.

B

Endothelial
Outgrowth

A

Endothelial
Outgrowth Threshold

Figure 25. Respective endothelial cell outgrowth images on NR (A) and R (B) dECM.

A

B

Figure 26. Respective thresholded endothelial cell outgrowth images on NR (A) and R (B)
dECM
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Figure 27. Relative endothelial cell outgrowth area on NR and R dECM.

IV.

CONCLUSIONS AND FUTURE WORK
The first aim of this work was to develop a fibroblast cell culture model that

allows for the production of a cardiovascular specific decellularized ECM. Human
cardiac fibroblasts were successfully cultured and used in order to produce a cellECM microenvironment.

This cell-ECM scaffold was then used in order to

elucidate the radiative effects on cell activity in an effort to connect radiation
exposure to fibrotic consequences. It was verified here that the ECM component
can be decellularized successfully using detergent based methods.

This HCF

derived dECM was then used in order to additionally study effects of exposure to
γ-radiation. Future studies on HCF derived dECM can supplement information
regarding its composition, microstructure, biochemical properties, and bioactivity
to those of its native organ
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Second, it was an aim of this work to study the radiosensitivities of the
fibroblastic model exposed to γ-radiation.

We verified that exposure to γ-

radiation increases the levels of ROS within the fibroblastic environment. ROS
are known activators of pro-fibrotic signaling cascades and have already been
linked to the activation and/or expression of pro-fibrotic growth factors and
proteins.

γ-H2AX foci studies completed support the idea that HCFs are

radiosensitive to increased ROS levels.
ROS has been shown to efficiently activate the TGF-β signaling pathway
which is a known player in the upregulation of fibrotic genes. It achieves its goal
through the activation of the SMAD 2/3 nuclear pathway which upon activation
upregulates fibrotic gene transcription.

Through examining both of these

proteins, this work verified that both proteins are sensitive in response to ROS
production thus suggesting that γ radiation exposure is also an activator of the
TGF-β1 and SMAD 2/3 pathway. Increased production of fibrotic proteins, as a
result of an activated SMAD 2/3 pathway, are normally characterized by the
presence of myofibroblasts.

We additionally verified that upon γ-radiation

exposure there is a significant increase in α-SMA expression, which is also ROS
sensitive. Collectively, this HCF activity suggests that downstream effects of γradiation exposure can include pro-fibrotic events in HCFs. We thus continued
our investigation into ECM level changes in response to γ-radiation exposure.
The ECM is the supportive framework for fibroblasts that mandate most
aspects of a cells life in-vivo and in-vitro. We utilized an HCF derived ECM in
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order to study the changes to the ECM function, including its composition,
structure, and effects on cellular activities post γ-radiation exposure. Fibronectin
is a key fibrotic protein that is known to be heavily influenced by the activity of
TGF-β1. We observed an inherent increase in fibronectin production, along with
increased TGF- β1, and additionally report that FN production is ROS sensitive, a
result strongly correlated with effects of pro-fibrotic cell signaling cascades
studied here.

Surprisingly, it was observed that both collagens decreased in

response to radiation exposure. This contradiction suggests collagen production
is mandated by more than just fibroblasts or moreover, modified post-radiation
by ECM remodeling proteins, such as cathepsins, and will be investigated further
in future studies. However, analysis of all proteins produced suggests a trend
globally supporting an increased protein production in response to γ-radiation
exposure.

Future work will include investigating the AOX treated conditions

when studying all proteins produced.
Structural studies examined the thickness and anisotropy of the ECM
produced post radiation exposure. Thickness of radiated dECM was increased
implying the presence of more proteins produced in radiative conditions.
Additionally, in the presence of AOX the thickness of dECMs were comparable to
NR groups.

Collectively, this relationship also implies protein production is

altered in response to γ-radiation and is dependent on the presence of ROS.
Moreover, the structural dispersion of ECM fibrils was studied by examining
anisotropy of the dECM produced. Under radiative conditions, the ECM is less
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ordered, or less anisotropic thus altering the fundamental structure of ECM.
Interestingly enough, not only is radiation a contributor to anisotropy, it was
shown here that exogenous AOX treatment has a significant toll on dECM
organization. This affect will have to be studied more in order to obtain a clearer
understanding of the chemistry involved in the treatment of the AOX cocktail and
its interactions with ECM molecules. Nonetheless, the alteration noted in radiated
samples (samples with the least anisotropy) in structure observed is known to
affect ECM characteristics possibly leading to the phenotypical conditions
observed in diseased cardiovascular states.
Lastly, endothelial cell outgrowth onto ECM was examined in response to
γ-radiation exposure in order to see if radiated ECM can alter a cells function.
Although not significant, a clear result of this study was that cell migration onto
ECM was hindered on radiated ECM. This is key in suggesting that the ECM
plays a critical role in determining the fate of cells in its environment, both under
not radiated and radiated conditions

Altered cell functions and activity are

certainly known to contribute to the conditions observed in diseased
cardiovascular states.
We hypothesized that an HCF in vitro model can be designed in order to
show that γ-radiation exposure increases ROS which contribute to the increased
production of ECM proteins thus, altering their structure and function.

We

investigated this task by completing radiosensitivity studies on HCFs and their
ECM, seeing a general trend supporting the idea the γ-radiation increases protein
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production and changes the molecular make up of cells and ECM. Moreover, it is
shown here that γ-radiation exposure appears to be strongly associated with profibrotic events characterized with many cardiovascular disease pathologies. This
is deducted by observing increased expression or activation of γ-H2AX, TGF-β1,
SMAD 2/3, α-SMA, increased FN and overall protein production, and an increase
in thickness and decrease in anisotropy. Clearly, this fibroblastic model has
proven itself to be able to provide a novel platform to study radiation-induced
changes to HCFs and ECM.
Future work will focus on improvements leading towards the progression
to study in-vivo changes such as: (1) utilize additional quantification techniques
to explore activation and production of proteins in both HCFs and dECM (2)
include nuclear level investigations of pro-fibrotic gene changes in similar
conditions and (3) expand the outgrowth assay to include an increased n-value
with the addition of AOX treated dECM conditions.
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